Form 4: ResMed CEO Michael Farrell Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
ResMed's CEO, Michael J. Farrell, exercised stock options and sold shares of ResMed Common Stock on April 7, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On April 7, 2025, Michael J. Farrell, the CEO of ResMed Inc., executed stock options to acquire 8,009 shares of ResMed Common Stock at a price of $101.64 per share.
- Simultaneously, Farrell sold 8,009 shares of ResMed Common Stock at a weighted average price of $209.8513, with individual sales prices ranging from $200.18 to $218.54.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on October 31, 2024.
- Following these transactions, Farrell directly owns 455,472 shares of ResMed Common Stock and indirectly owns 2,090 shares through the Lisette and Michael Farrell Family Trust.
- Farrell also directly owns 56,065 ResMed Common Stock Options.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans like Rule 10b5-1 to avoid accusations of trading on inside information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates any significant surprise.
Key Dates
| Date | Description |
|---|---|
| 11/11/2019 | Date options first become exercisable. |
| 10/31/2024 | Date Rule 10b5-1 plan was adopted. |
| 04/07/2025 | Date of stock option exercise and share sale. |
| 04/08/2025 | Date of signature on the Form 4. |
| 11/14/2025 | Expiration date of the options. |
Keywords
ResMed, Michael J. Farrell, Stock Options, Share Sale, Rule 10b5-1, Insider Trading, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.